CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Net Inc. Y/Y Annual
Aura Biosciences Inc   (AURA)
Other Ticker:  
 
 

AURA's Net Income Growth by Quarter and Year

Aura Biosciences Inc 's Net Income results by quarter and year




AURA Net Income (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - -16.56 8.84 0.00
III Quarter September - -15.90 -8.84 0.00
II Quarter June -18.30 -13.47 0.00 0.00
I Quarter March -17.47 -12.84 0.00 0.00
FY   -35.77 -58.77 0.00 0.00



AURA Net Income second quarter 2023 Y/Y Growth Comment
Aura Biosciences Inc in the second quarter 2023 recorded net loss of $ -18.30 millions.

According to the results reported in the second quarter 2023, Aura Biosciences Inc achieved the best Net Income growth in Biotechnology & Pharmaceuticals industry. While Aura Biosciences Inc ' s Net Income no change of % ranks overall at the positon no. in the second quarter 2023.


AURA Net Income ( Y/Y Growth %) 2023
 2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Aura Biosciences Inc 's second quarter 2023 Net Income $ -18.30 millions AURA's Income Statement
Aura Biosciences Inc 's second quarter 2022 Net Income $ -13.47 millions Quarterly AURA's Income Statement
New: More AURA's historic Net Income Growth >>


AURA Net Income (Quarter on Quarter Growth %)

 2023
 2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -


Compare AURA Profitability >> Back to AURA Growth rate Comparisons >>


Net Income second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Income second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Income by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Aura Biosciences Inc 's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


AURA's II. Quarter Q/Q Net Income Comment
Recent net loss of -18.30 millions by Aura Biosciences Inc come out even less good considering the -17.47 millions net loss a quarter before.

Within Biotechnology & Pharmaceuticals industry Aura Biosciences Inc achieved highest sequential Net Income growth. While Aura Biosciences Inc 's Net Income growth quarter on quarter, overall rank is .


Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


AURA's II. Quarter Q/Q Net Income Comment
II. Quarter 2023 net loss of -18.30 millions by Aura Biosciences Inc appear even more unfavourable considering the -17.47 millions net loss a quarter before.

Within Biotechnology & Pharmaceuticals industry Aura Biosciences Inc achieved highest sequential Net Income growth. While Aura Biosciences Inc 's Net Income growth quarter on quarter, overall rank is .


Aura Biosciences Inc 's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Jun 30 2023)		 12 Months Ending
(Mar 31 2023)		 12 Months Ending
(Dec 31 2022)		 12 Months Ending
(Sep 30 2022)		 12 Months Ending
(Jun 30 2022)
Cumulative Net Income 12 Months Ending $ -68.23 $ -63.39 $ -58.76 $ -33.37 $ -26.30
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) - - - - -
Seq. Net Income Growth (TTM) Overall Ranking # # # # #

New: More AURA's historic Net Income Growth >>



Cumulative Net Income growth Comment
Aura Biosciences Inc ' has realized cumulative trailing twelve months net loss of $ -68 millions in the Jun 30 2023 period.
The business is worsening as the cumulative net loss is inflating from $ -63.39 millions in TTM ending quarter Mar 31 2023 and $ millions for the twelve months ending in the quarter Jun 30 2022.

Aura Biosciences Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Income growth Comment
Aura Biosciences Inc ' has realized cumulative trailing twelve months net loss of $ -68 millions in the Jun 30 2023 period.
The situation is getting worse as the cumulative net loss is becoming larger from $ -63.39 millions in TTM ending quarter Mar 31 2023 and $ millions for the twelve months ending in the quarter Jun 30 2022.

Aura Biosciences Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Income Growth
Biotechnology & Pharmaceuticals Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
AURA's Net Income Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for AURA's Competitors
Net Income Growth for Aura Biosciences Inc 's Suppliers
Net Income Growth for AURA's Customers

You may also want to know
AURA's Annual Growth Rates AURA's Profitability Ratios AURA's Asset Turnover Ratio AURA's Dividend Growth
AURA's Roe AURA's Valuation Ratios AURA's Financial Strength Ratios AURA's Dividend Payout Ratio
AURA's Roa AURA's Inventory Turnover Ratio AURA's Growth Rates AURA's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Jun 30 2023 within Healthcare SectorY/Y Change %Net Income for the quarter ending Jun 30 2023
Phibro Animal Health Corporation53.57%$ 53.573 millions
Amphastar Pharmaceuticals Inc 50.61%$ 50.605 millions
Harmony Biosciences Holdings inc 45.77%$ 45.765 millions
Bristol myers Squibb Company45.35%$ 45.346 millions
Semler Scientific inc 44.31%$ 44.305 millions
Pacific Health Care Organization Inc 41.68%$ 41.681 millions
Msa Safety Inc40.67%$ 40.671 millions
Select Medical Holdings Corp38.63%$ 38.631 millions
Vaso Corporation38.60%$ 38.595 millions
Zimmer Biomet Holdings Inc 36.23%$ 36.234 millions
Intuitive Surgical Inc 35.84%$ 35.842 millions
Ufp Technologies Inc33.08%$ 33.083 millions
Merit Medical Systems Inc32.34%$ 32.338 millions
Addus Homecare Corporation32.02%$ 32.018 millions
Pacira Biosciences inc 29.62%$ 29.619 millions
Iradimed Corporation28.97%$ 28.966 millions
Zoetis Inc 26.65%$ 26.654 millions
Incyte Corporation26.09%$ 26.089 millions
Healthcare Services Group Inc 26.07%$ 26.070 millions
Medpace Holdings Inc 23.72%$ 23.720 millions
Bio techne Corp21.92%$ 21.917 millions
Ir med Inc 18.10%$ 18.104 millions


Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com